Dashboard
Manage Tickers

LLYELI LILLY & Co

NYSE lilly.com


$ 900.84 $ -7.02 (-0.77 %)    

Tuesday, 10-Sep-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 458.06 $ 4.20 (0.92 %)
DIA $ 408.23 $ -0.79 (-0.19 %)
SPY $ 548.63 $ 2.38 (0.44 %)
TLT $ 100.67 $ 0.70 (0.7 %)
GLD $ 232.64 $ 1.02 (0.44 %)
$ 901.25
$ 914.78
$ 901.02 x 100
-- x --
$ 895.30 - $ 914.98
$ 513.12 - $ 972.53
1,930,385
na
856.57B
$ 0.59
$ 116.66
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 04-30-2024 03-31-2024 10-Q
3 02-21-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 04-27-2023 03-31-2023 10-Q
7 02-22-2023 12-31-2022 10-K
8 11-01-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 04-29-2022 03-31-2022 10-Q
11 02-23-2022 12-31-2021 10-K
12 10-27-2021 09-30-2021 10-Q
13 08-03-2021 06-30-2021 10-Q
14 04-30-2021 03-31-2021 10-Q
15 02-17-2021 12-31-2020 10-K
16 10-28-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 05-01-2020 03-31-2020 10-Q
19 02-19-2020 12-31-2019 10-K
20 10-25-2019 09-30-2019 10-Q
21 08-02-2019 06-30-2019 10-Q
22 05-02-2019 03-31-2019 10-Q
23 02-19-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 07-25-2018 06-30-2018 10-Q
26 04-27-2018 03-31-2018 10-Q
27 02-20-2018 12-31-2017 10-K
28 10-27-2017 09-30-2017 10-Q
29 07-28-2017 06-30-2017 10-Q
30 05-01-2017 03-31-2017 10-Q
31 02-21-2017 12-31-2016 10-K
32 10-28-2016 09-30-2016 10-Q
33 07-28-2016 06-30-2016 10-Q
34 04-29-2016 03-31-2016 10-Q
35 02-19-2016 12-31-2015 10-K
36 10-30-2015 09-30-2015 10-Q
37 07-30-2015 06-30-2015 10-Q
38 04-30-2015 03-31-2015 10-Q
39 02-19-2015 12-31-2014 10-K
40 10-29-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

heres-how-much-you-would-have-made-owning-eli-lilly-stock-in-the-last-20-years
Here's How Much You Would Have Made Owning...
09/10/2024 20:00:20

eli-lillys-once-weekly-insulin-efsitora-alfa-achieves-comparable-a1c-reduction-to-daily-insulin-degludec-in-phase-3-qwint-2-trial-results-published-in-nejm-and-presented-at-easd-2024-efsitora-reduced-a1c-by-134-compared-to-126-for-insulin-degludec
Eli Lilly's Once-Weekly Insulin Efsitora A...
09/10/2024 15:27:54

In QWINT-2, efsitora helped adults naïve to insulin therapy currently using and not using GLP-1 receptor agonists achieve an A1...

zepbound-and-mounjaro-maker-eli-illy-has-a-new-cfo-as-it-navigates-regulatory-challenges-what-you-should-know
Zepbound And Mounjaro Maker Eli Illy Has A...
09/10/2024 03:00:59

Eli Lilly and Company has appointed Lucas Montarce as executive vice president and chief financial officer, effective immediate...

a-glimpse-into-the-expert-outlook-on-eli-lilly-through-28-analysts
A Glimpse Into The Expert Outlook On Eli L...
09/09/2024 20:00:18

cantor-fitzgerald-reiterates-overweight-on-eli-lilly-maintains-885-price-target
Cantor Fitzgerald Reiterates Overweight on...
09/09/2024 15:47:21

Cantor Fitzgerald analyst Louise Chen reiterates Eli Lilly (NYSE:LLY) with a Overweight and maintains $885 price target.

smart-money-is-betting-big-in-lly-options
Smart Money Is Betting Big In LLY Options
09/09/2024 14:15:56

eli-lilly-appoints-lucas-montarce-as-executive-vice-president-and-cfo-effective-immediately
Eli Lilly Appoints Lucas Montarce As Execu...
09/09/2024 10:46:23

innovent-bio-hopes-for-plus-sized-profits-from-obesity-drug
Innovent Bio hopes for plus-sized profits ...
09/06/2024 19:16:41

Key Takeaways: Sales approval for the company’s anti-obesity drug mazdutide may drag out beyond this year, potentially allow...

fda-battles-backlog-of-drug-factory-inspections-since-covid-19
FDA Battles Backlog of Drug Factory Inspec...
09/06/2024 15:52:51

FDA faces inspection backlog with serious public health implications, as critical drug manufacturing plants remain unchecked.

stock-of-the-day-heres-why-weight-loss-drug-maker-eli-lilly-has-reversed
Stock Of The Day: Here's Why Weight-Loss D...
09/06/2024 15:25:39

Shares of Eli Lilly hit resistance at the $955 level. Now they are heading lower. These moves are due to investor psychology.

comparative-study-eli-lilly-and-industry-competitors-in-pharmaceuticals-industry
Comparative Study: Eli Lilly And Industry ...
09/06/2024 15:00:14

fake-ozempic-targets-weight-loss-market-forged-batches-an-international-concern
Fake Ozempic Targets Weight-Loss Market: F...
09/05/2024 17:17:20

Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting operation...

battle-over-compounded-weight-loss-medications---sustainability-and-regulation
Battle Over Compounded Weight-Loss Medicat...
09/05/2024 16:47:47

Explore how Hims & Hers competes with big pharma amid weight-loss drug shortages, offering cheaper alternatives and facing ...

eli-lillys-once-weekly-insulin-shows-non-inferior-blood-sugar-reduction-vs-frequently-used-daily-insulins-in-long-term-trials
Eli Lilly's Once-Weekly Insulin Shows Non-...
09/05/2024 13:47:18

Eli Lilly's Weekly Insulin Efsitora Meets Phase 3 Goals, Offering Improved Blood Sugar Control in Type 2 Diabetes.

eli-lillys-once-weekly-insulin-trials-show-similar-a1c-reduction-as-daily-doses-improving-diabetes-management-potential
Eli Lilly's Once-Weekly Insulin Trials Sho...
09/05/2024 10:50:03

Eli Lilly and Company (NYSE:LLY) today announced positive topline results from the QWINT-1 and QWINT-3 phase 3 clinical trials ...

Core News & Articles
QIAGEN Enters Collaboration With Eli Lilly...
09/04/2024 20:29:07

This collaboration represents a significant milestone as the QIAstat-Dx panel would be the first commercially available IVD for...

bioage-labs-files-for-100m-ipo-becomes-the-new-entrant-in-obesity-drugs-race
BioAge Labs Files For $100M IPO, Becomes T...
09/04/2024 15:13:09

BioAge Labs a biotech company focused on therapies for metabolic diseases, has filed for a $100 million IPO. Founded in 2015, t...

Core News & Articles
MHRA Finds No Evidence Supporting Link Bet...
09/04/2024 14:52:07

- Reuters 

trade-pulse-power-inflow-alert-eli-lilly-stock-rises-over-7-points
Trade Pulse Power Inflow Alert: Eli Lilly ...
09/04/2024 13:02:16

Core News & Articles
Eli Lilly And EVA Pharma Entered Into An A...
09/04/2024 10:06:33

Discovered By Incyte And Licensed To Lilly, Baricitinib Is For The Treatment Of Rheumatoid Arthritis, Alopecia Areata, Atopic D...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION